Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07594964RecruitingPhase 1
Safety Study of XH001 Injection for High-Risk Recurrent Solid Tumors
This early-stage trial tests a new injection called XH001 as an additional treatment after surgery for patients with high-risk cancers that have come back. The goal is to check if it's safe and whether it helps prevent the cancer from returning again.
BeijingAges 18–70 - NCT07595367RecruitingPhase 2
BBD-1 immune therapy for IgA vasculitis
This trial tests a new drug called BBD-1 that may help treat IgA vasculitis, a condition where your immune system attacks small blood vessels, causing a purple rash and organ damage. The study measures how well BBD-1 reduces symptoms and side effects.
Baltimore, MarylandAges Any age - NCT07602088Recruiting
Real-world Study of Two Cancer Drugs for Chronic Lymphocytic Leukemia
This study follows patients with chronic lymphocytic leukemia (CLL)—a blood cancer—who are starting treatment with two drugs called ibrutinib and venetoclax together for a set period of time. Researchers want to understand how well this treatment works and how it affects patients' daily lives in real-world settings, rather than in a controlled lab environment.
BucharestAges 18 years+ - NCT07603193Enrolling by invitation
Real-World Study of Delgocitinib Cream for Chronic Hand Eczema
This study tracks how well delgocitinib cream works and how safe it is for people with chronic hand eczema in everyday use. Researchers collect information from your doctor visits to understand if this treatment helps manage your hand eczema symptoms.
Neu-IsenburgAges 18 years+ - NCT07596485RecruitingPhase 1/Phase 2
RP-008 Plus Varenicline for Trigeminal Neuralgia Pain
This trial tests a new drug called RP-008 combined with varenicline (a quit-smoking medication) to relieve severe facial pain from trigeminal neuralgia. If you've already tried standard pain medications without enough relief, this combination might help reduce your pain attacks.
SherbrookeAges 18–80 - NCT07597993Recruiting
Real-world study of Trastuzumab Deruxtecan for advanced breast cancer
This study follows women with advanced breast cancer (metastatic) who have hormone-receptor positive tumors and low HER2 levels, to see how well a new drug called Trastuzumab Deruxtecan works when used in routine clinical care after prior hormone therapy.
MuscatAges 18 years+ - NCT07598708RecruitingPhase 2/Phase 3
Cleminorexton for Narcolepsy: A New Treatment Study
This study tests whether a new medication called cleminorexton helps people with narcolepsy (a condition causing severe daytime sleepiness) sleep better and feel more alert. You would take this medication instead of your current narcolepsy drugs for several months to see if it works.
Birmingham, AlabamaAges 18–70 - NCT06716164RecruitingEarly Phase 1
Experimental car-t cell therapy for relapsed b-cell lymphoma
This trial tests a new type of CAR-T cell therapy designed to be stronger against B-cell lymphoma that has come back or not responded to previous treatments. The treatment uses your own immune cells, which are modified in a lab to better attack cancer cells.
Hangzhou, ZhejiangAges 19–70 - NCT06714734Recruiting
Blood thinners in cancer patients with blood clots
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
BolognaAges 18 years+ - NCT06714721Recruiting
Magnetic diaphragm stimulation for COPD
This study tests if magnetic stimulation of the diaphragm muscle can help people with COPD breathe better. If you have had COPD for at least 6 months, are over 18, and can answer questionnaires, you may be eligible.
AnkaraAges 18 years+ - NCT03168802Recruiting
Ultrasound and nerve treatment for facet-joint low back pain
This study tests whether a procedure that uses focused ultrasound (MRgFUS) and/or a radiofrequency nerve treatment can reduce long-lasting low back pain caused by facet-joint arthritis. It may help people whose pain improves strongly after a targeted numbing injection to specific back nerves.
Taipei, Please SelectAges 20–79 - NCT06717048Recruiting
Finding the best red light therapy for myopia in children
This study tests whether a special red light therapy can help slow down the progression of nearsightedness in children. It compares different amounts of light and how often it is used to find the best way to keep myopia from getting worse.
Shanghai, Shanghai MunicipalityAges 8–10 - NCT06716541Recruiting
Biodegradable stent for bile duct narrowing after liver transplant
This study is testing a special temporary stent that breaks down over time to help open a narrowed bile duct after a liver transplant. It may help avoid long-term plastic stents or additional surgery.
PragueAges 18 years+ - NCT07596147Recruiting
Early Movement Training for At-Risk Infants
This trial tests an early intervention program called SAFE for babies aged 3–12 months who had complications at birth or were born prematurely. The goal is to help their brain and movement development through specialized therapy.
Ankara, AnkaraAges 3 months–1 year - NCT07595705RecruitingPhase 2
Testing gum pigmentation removal treatments
This study tests treatments to lighten dark spots or patches on your gums for cosmetic reasons. If you have visible brown or black discoloration on your gums and are interested in a minor procedure to improve their appearance, this trial may be for you.
Al Fayyum, Faiyum GovernorateAges 18 years+ - NCT07600424Recruiting
Ear Stimulation Device for Moderate to Severe Facial Redness
This trial tests a small device worn on your ear that sends gentle electrical signals to a nerve, aiming to reduce facial redness and flushing from rosacea. The device may help calm the inflammation that causes rosacea symptoms.
Boston, MassachusettsAges 18 years+ - NCT07596654Recruiting
Surgery versus chemotherapy for early-stage small cell esophageal cancer
This study compares how well surgery works compared to chemotherapy and radiation for treating small cell cancer that started in the esophagus and hasn't spread far. Researchers will examine which approach helps patients live longer.
Nanjing, JiangsuAges 18 years+ - NCT07598578RecruitingEarly Phase 1
New drug combination for hard-to-treat T-cell lymphoma
This study tests a combination of three drugs (azacitidine, chidamide, and a PD-1 inhibitor) for T-cell lymphomas that have returned or stopped responding to previous treatment. The goal is to see if this combination can help shrink the cancer.
SuzhouAges 18–75 - NCT07596394Recruiting
Registry of Catheter-Based Aortic Valve Replacements
This registry collects information about patients who receive a new valve inserted through a catheter (a thin tube) rather than open surgery. It tracks how well the procedure works and any side effects to help doctors understand the long-term safety and effectiveness of this less invasive approach.
Pavia, PaviaAges 18 years+ - NCT07601737RecruitingPhase 2
Nimotuzumab with immunotherapy and chemotherapy for head and neck cancer
This trial tests a combination of three treatments—nimotuzumab (a targeted therapy), a PD-1 inhibitor (which boosts your immune system), and chemotherapy—followed by surgery for locally advanced head and neck squamous cell carcinoma. The goal is to shrink the tumor and improve survival.
ShanghaiAges 18–75 - NCT07601932Recruiting
Patient Positioning During Kidney Stone Removal Surgery
This study compares different patient body positions during a minimally invasive procedure (flexible ureteroscopy) to remove kidney stones from the upper ureter. The goal is to find the best positioning to make stone removal easier and more successful.
New York, New YorkAges 18 years+ - NCT07600892Enrolling by invitation
Pain-at-Work Toolkit for managing chronic pain at work
This study tests a toolkit designed to help working adults manage chronic pain while on the job. The toolkit aims to make work more manageable and enjoyable for people living with ongoing pain.
Nottingham, NottinghamshireAges 18 years+ - NCT07600840Enrolling by invitation
Smart Watch and App for Understanding and Treating Sleep Problems
This study tests a combination of a wearable smart watch, brain-wave monitor (EEG), and smartphone app designed to help understand your sleep problems and emotions. The goal is to develop a digital tool that tracks your sleep patterns and mood to improve insomnia treatment.
Taipei, TaipeiAges 18–64 - NCT07599371RecruitingPhase 1/Phase 2
Ivoximab and temozolomide for recurring brain tumors
This trial tests a combination of two drugs—ivoximab (a new immunotherapy) and temozolomide (chemotherapy)—to treat gliomas (brain tumors) that have come back or stopped responding to prior treatment. The goal is to see if this combination is safe and effective.
Zhengzhou, HenanAges 18–85
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.